Earnings News

Latest earnings news and updates for US-listed public companies.

📣 Get earnings alerts and analysis

STRADVISION Reports Strong First Half of 2025, Expands SVNet Deployment

Nearly 1 Million SVNet-Equipped Vehicles Added in H1 2025: achieved growth despite regional slowdowns and heightened industry competition Unmatched Efficiency Driving Market Leadership: SVNet's ult...

Will the regional slowdowns mentioned in the release materially impact the company’s cash flow or require adjustments to its capital allocation and growth strategy? What competitive advantages does SVNet’s ultra‑lightweight AI architecture provide versus rival AI platforms, and how sustainable are these advantages amid increased industry competition? How will the addition of nearly 1 million SVNet‑equipped vehicles in H1 2025 affect STRADVISION's revenue guidance and earnings per share outlook?
Symbol: STRA
21 days ago
Read more prnewswire

SFL - Second Quarter 2025 Results Presentation

Please find enclosed the presentation of the preliminary second quarter results to be held August 19, 2025, in the link below.

What implications do the Q2 results have for SFL's short‑term stock price movement and long‑term growth outlook? How does SFL's Q2 2025 performance compare to analyst expectations and its own guidance for the year? What were the primary factors influencing SFL's Q2 2025 earnings and revenue results?
Symbol: SFL
21 days ago
Read more globenewswire

NeOnc Technologies Holdings Reports Second Quarter 2025 Results and Provides Operational Update

CALABASAS, Calif. and ABU DHABI, United Arab Emirates, Aug. 19, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a multi–Phase 2 clinical-stage biotechnology company pio...

How does NeOnc's operational update compare to peer biotech companies targeting CNS cancers? What are the implications of the reported cash runway and burn rate for future financing needs? How will the upcoming Phase 2 data readouts affect NTHI's valuation?
Symbol: NTHI
21 days ago
Read more globenewswire

WuXi Biologics Reports Solid 2025 Interim Results

Revenue increased by 16.1% YoY to RMB 9,953.2 million; revenue growth from continuing operations was 20.2% IFRS Gross profit margin expanded by 3.6% YoY to 42.7% EBITDA grew 50.5% YoY and IFRS net ...

Will the strong adjusted EBITDA and net profit growth translate into higher dividend payouts or share buybacks, and what is the expected impact on the stock price trajectory? What are the drivers behind the 50.5% YoY EBITDA increase and how sustainable are they compared to peers in the CDMO sector? How will the 20.2% revenue growth from continuing operations and expanding gross margin affect WuXi Biologics' valuation multiples?
Symbol: WUS
21 days ago
Read more prnewswire

Research Solutions Reports Preliminary Fourth Quarter and Fiscal Year 2025 Results

Expects Record Fiscal Year Revenue, Net Income, Adjusted EBITDA and Cash Flow HENDERSON, Nev., Aug. 19, 2025 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), the leading AI-powered research...

What potential risks or uncertainties could impact the preliminary results and the company's guidance for FY2025? What are the assumptions behind the projected adjusted EBITDA and cash flow, and how do they compare to consensus estimates? How will the record fiscal year revenue and net income forecasts affect the valuation of RSSS?
Symbol: RSSS
21 days ago
Read more prnewswire